A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)
Clinical trial NCT03875495 · TERMINATED
Trial details
- NCT number
- NCT03875495
- Sponsor
- Genenta Science
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-06
- Primary completion
- 2021-04-02
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.